biotech
biotech Articles
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
Published:
Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon Therapeutics shareholders getting enough out of the deal?
Published:
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Published:
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Published:
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
Published:
Adaptimmune shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform.
Published:
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
Published:
Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its midstage trial in X-linked retinitis pigmentosa.
Published:
DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with a peanut allergy.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
Xeris Pharmaceuticals shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults with Type 1 diabetes mellitus.
Published:
Apellis Pharmaceuticals shares jumped on Tuesday after the firm announced positive results from its late stage study in adults with paroxysmal nocturnal hemoglobinuria (PNH). Specifically, the data...
Published:
On a company by company basis, investing in biotechs is somewhat tricky. However, there is an investment strategy that makes it much easier.
Published: